Effects of Nebivolol on Subclinical left ventricular dysfunction. A comparative study against Metoprolol.

Trial Profile

Effects of Nebivolol on Subclinical left ventricular dysfunction. A comparative study against Metoprolol.

Completed
Phase of Trial: Phase III

Latest Information Update: 09 Dec 2009

At a glance

  • Drugs Metoprolol; Nebivolol
  • Indications Hypertension; Left ventricular dysfunction
  • Focus Pharmacodynamics
  • Acronyms ENESYS
  • Sponsors Menarini
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 22 Jul 2009 Actual patient number (60) added as reported by ClinicalTrials.gov.
    • 22 Jul 2009 Actual end date (1 Jul 2009) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top